Acorda Therapeutics, Inc.

Acorda Therapeutics, Inc.

ACOR
Acorda Therapeutics, Inc.US flagNASDAQ Global Select
0.66
USD
-0.21
- -
821,028.00Market Cap

Acorda Therapeutics, Inc. (ACOR) Stock Split History

Learn about Acorda Therapeutics, Inc.'s most recent 1-for-20 basis stock split on June 05, 2023. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Acorda Therapeutics, Inc.'s most recent stock split

Split Date: 2023-06-05
Split Ratio: 1:20
Price Before Split: $0.08
Price After Split: $0.00

Developer API

Get ACOR split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/ACOR

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 20.00 times fewer shares (a 1:20 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of Acorda Therapeutics, Inc.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2023-06-051:20Yes$0.08$0.00
2021-01-041:6Yes$0.11$0.02

About Acorda Therapeutics, Inc.

Company overview and industry information

Acorda Therapeutics, Inc. (ACOR) operates in the Drug Manufacturers - Specialty & Generic industry. The recent 1-for-20 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Drug Manufacturers - Specialty & Generic
Go to Acorda Therapeutics, Inc. Summary

Last updated: 7/5/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.